Skip to main content
. 2015 Dec 28;145(1):79–86. doi: 10.1378/chest.13-1186

Table 3.

—Complications, Management, and Prognosis of Patients With Adenoviral Pneumonia

Characteristics Total (N = 48) HAdV-55 (n = 21) Other Types (n = 27) P Value
Hospitalization 26 (54.2) 11 (52.4) 15 (55.6) 1.0
Complications
 Coinfection with bacteria 0 (0) 0 (0) 0 (0)
 Coinfection with Mycoplasma pneumoniae 6 (12.5) 3 (14.3) 3 (11.1) 1.0
 Coinfection with other respiratory virus 12 (25) 4 (19.1) 7 (25.9) .726
 ARDS 2 (4.2) 0 (0) 2 (7.4) .497
Management
 Oxygen therapy 14 (29.2) 7 (33.3) 7 (25.9) .750
 Mechanical ventilation 2 (4.2) 0 (0) 2 (7.4) .497
 Antibiotics 48 (100) 21 (100) 27 (100) 1.0
 Antivirala 4 (8.3) 4 (19.1) 0 (0) .031
Outcomes
 Duration of fever, d 6 (2-20) 7 (2-20) 5 (2-9) .201
 Duration of cough, d 14.5 (4-37) 14.5 (5-37) 14 (4-28) .810
 Duration of sputum, d 13.5 (4-37) 13.5 (4-37) 12 (6-29) 1.0
 Duration of dyspnea, d 6 (1-21) 6 (2-11) 6 (1-21) .905
 Duration of chest pain, d 5 (5-7) 5 (5-5) 6 (5-7) .667
 LOS in hospital, d 7.5 (3-26) 9 (5-21) 6 (3-26) .087
 Hospitalization expenses, RMB 6,020 (1,200-49,947) 7,608 (4,229-32,684) 4,865 (1,200-49,947) .234

Data are presented as No. (%) or median (range). LOS = length of stay; RMB = Chinese Yuan. See Table 1 legend for expansion of other abbreviations.

a

Three of the patients were prescribed acyclovir and the fourth was given ribavirin. All the patients were from Beijing Chao-Yang Hospital.